United States flag

Finance - FP & A Manager

United States - California - Foster CityFinance & AccountingRegular

Descrizione del lavoro

The Finance Manager, R&D Portfolio will drive strategic financial analyses and processes for month-end close activities and reporting execution for R&D. The position requires strategy, planning, leadership, and cross-functional partnership for month-end close and planning cycles, along with in-depth drug development finance knowledge. As Gilead continues to evolve, we need to create, execute and support thoughtfully structured processes for a successful month-end close and IPR&D management. This will ensure that we are prepared for Corporate deliverables and set up for effective business partnering with the Chief Medical Officer (CMO) and Development Leadership Team (DLT). The role will report to the Sr Director, R&D ST Portfolio Finance, and will have an enterprise responsibility in being technically strong and partnering across multiple stakeholders within FP&A functions (R&D, PDM, Kite, and Corporate).

Core Responsibilities:

  • Manage and lead the month-end close for R&D functions, including management review meetings, R&D Close Package, IPE and SOX compliance deliverables, SEC reporting, etc.

  • Collaborate cross-functionally with FP&A and Controllership to drive month-end close timelines, effectively communicate deliverables, and synthesize key drivers to craft final R&D commentary for Corporate reporting

  • Own the end-to-end IPR&D process for month-end close and planning cycles, partnering with FP&A, Corporate, Alliance Management, and Controllership

  • Develop executive-level reports and presentations for CMO’s monthly management reviews

  • Leverage ERP systems to extract, analyze, and report financial data with advanced system capability

  • Support ad-hoc analysis and special projects, including completion of annual industry surveys

  • Proactively identify and implement process improvements to enhance efficiency and effectiveness of financial reporting and analysis

Capabilities and Requirements:

  • BS or BA is required, and an MBA or CPA is strongly preferred

  • Minimum of 6 years of finance experience with increasing scope and responsibility, 4 years with an MBA

  • MBA or Master of Accounting preferred

  • Management experience is a plus

  • Prior experience in biotech or pharma in a commercial finance role is strongly preferred

  • In-depth proficiency in aspects of accounting and finance and knowledge of US GAAP is required

  • In depth knowledge of, Planning and ERP systems is required with proficiency in Microsoft tools

  • Experience in high growth, multinational organization is a plus

  • Relevant experience typically includes budget development, clinical development, or corporate finance within pharma industry

  • Familiarity with operational tools such as six-sigma, lean, and process mapping a plus

  • Advanced certification (PMP, etc.) a plus

Competencies:

  • Excellent interpersonal skills: an inquisitive mind, and the ability to work effectively with multiple functions

  • Highly organized with a strong attention to detail for managing tasks and information

  • Ability to quickly establish credibility with diverse audiences and be perceived as a strong contributor

  • Business Savvy and Financial Acumen: The candidate will possess technical knowledge on analytics, business foresight, and problem-solving skills

  • Results Orientation: The ideal candidate will be results-driven and must thrive in a fast-paced, dynamic environment. They must have the ability to deliver results and possess a strong drive to meet and exceed goals and is willing to take ownership of problems and make sound decisions.

  • Change Leadership: The candidate will be an independent self-starter and a proactive team player with a drive to strive for continuous improvement and consistently challenging the status quo. Will be viewed by business partners and Finance colleagues as a collaborative team member with strong, influencing capabilities, who can also maintain open and transparent communication channels.